These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2568788)
1. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States. Goldstein HA; Pfennig D Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():167-70. PubMed ID: 2568788 [TBL] [Abstract][Full Text] [Related]
2. [A randomized, double-blind clinical trial of 2 nonionic contrast media for myelography]. Lovrencić M; Klanfar Z; Jakovac I Lijec Vjesn; 1986 Apr; 108(4):141-6. PubMed ID: 3520199 [No Abstract] [Full Text] [Related]
3. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography. Wenzel-Hora BI; Potthoff PC; Jänicke UA Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():148-52. PubMed ID: 2568783 [TBL] [Abstract][Full Text] [Related]
4. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium. Shaw DD; Bach-Gansmo T; Dahlstrom K Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616 [TBL] [Abstract][Full Text] [Related]
5. Iotrolan versus iopamidol: a controlled, multicenter, double-blind study of lumbar and direct cervical myelography. Ringel K; Klotz E; Wenzel-Hora BI Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():153-7. PubMed ID: 2568784 [TBL] [Abstract][Full Text] [Related]
6. Comparative clinical study with iotrolan versus metrizamide in lumbar myelography. Inoue S; Watanabe T; Yamamura H Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():161-6. PubMed ID: 2568787 [TBL] [Abstract][Full Text] [Related]
7. Iotrol versus metrizamide in lumbar myelography: a double-blind study. Malnor MD; Houston LW; Strother CM; Turski PA; Sackett JF; Boyer M Radiology; 1986 Mar; 158(3):845-7. PubMed ID: 3945762 [TBL] [Abstract][Full Text] [Related]
8. [Clinical experience of iotrolan]. Ishikawa M; Handa H Nihon Geka Hokan; 1986 May; 55(3):485-9. PubMed ID: 3800545 [No Abstract] [Full Text] [Related]
9. Iohexol 240 mgr I/ml and metrizamide 240 mgr I/ml in lumbar myelography. Report from a randomized double blind study. Valk J; Hazenberg GJ; van Duijn H; Crezee F; Olislagers-De Slegte R Diagn Imaging Clin Med; 1986; 55(3):114-20. PubMed ID: 3522040 [TBL] [Abstract][Full Text] [Related]
10. Urography with monomeric and dimeric nonionic contrast media: comparative, randomized, double-blind study of iotrolan 280 and iopromide 300. Taenzer V; Wenzel-Hora BI Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():116-8. PubMed ID: 2568778 [TBL] [Abstract][Full Text] [Related]
11. Iotrolan, a nonionic dimeric contrast medium in myelography. Bien S; Schumacher M; Berger W; Wenzel-Hora BI Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():158-60. PubMed ID: 2568785 [TBL] [Abstract][Full Text] [Related]
13. [Iopromide versus ioglicinate in dynamic computer tomography--a randomized controlled double-blind study]. Lindner R; Gailer H; Richter EI Rontgenpraxis; 1984 Oct; 37(10):362-6. PubMed ID: 6390726 [No Abstract] [Full Text] [Related]
14. Initial experience with a nonionic, dimeric contrast medium (iotrolan) in direct and indirect arteriography: a randomized, intraindividual double-blind study in 60 patients. Hagen B; Wenzel-Hora BI Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():54-60. PubMed ID: 2568808 [TBL] [Abstract][Full Text] [Related]
15. Metrizamide cisternography with hypocycloidal tomography: preliminary results. Roberson GH; Brismar J; Davis KR; Taveras JM; Weiss A AJR Am J Roentgenol; 1976 Dec; 127(6):965-7. PubMed ID: 998834 [TBL] [Abstract][Full Text] [Related]
16. Comparison of iohexol with metrizamide in myelography. Sortland O; Nestvold K; Kloster R; Aandahl MH Radiology; 1984 Apr; 151(1):121-2. PubMed ID: 6701301 [TBL] [Abstract][Full Text] [Related]
17. Tolerance to iotrolan after subarachnoid injection in animals. Press WR; Mützel W; Schöbel C Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():126-33. PubMed ID: 2568780 [TBL] [Abstract][Full Text] [Related]
18. Neural tolerance of iotrolan 300 in ascending cervical myelography: results of a multicenter study. Behrends B; Albrecht A; Bingas B; Becker H; Brunke J; von Einsiedel H; Mariss G; Schmidt K; Thun F; Valavanis A Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():171-5. PubMed ID: 2568789 [TBL] [Abstract][Full Text] [Related]
19. [Adverse reactions and intracranial contrast medium after myelography]. Fujii K; Hashimoto T; Isaza M; Hashimoto T; Hirabuki N; Miura T; Mitomo M; Kozuka T; Kawai R Rinsho Hoshasen; 1989 Mar; 34(3):323-7. PubMed ID: 2739082 [TBL] [Abstract][Full Text] [Related]
20. Urography with non-ionic contrast media: II. Diagnostic quality and tolerance of iopromide in comparison with ioxaglate. Taenzer V; Meiisel P; Hartwig P Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():153-5. PubMed ID: 6139071 [No Abstract] [Full Text] [Related] [Next] [New Search]